Viewing Study NCT00941460


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-05-17 @ 11:59 AM
Study NCT ID: NCT00941460
Status: COMPLETED
Last Update Posted: 2014-08-15
First Post: 2009-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
Sponsor: Prof. Dr. Wolfgang Wick
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None progressive or recurrent glioblastoma View
None temozolomide View
None dose intensification View
None comparison of two dosing regimens View